Liquiritigenin reduces osteoclast activity in zebrafish model of glucocorticoid-induced osteoporosis
Drug and therapies currently used to treat human bone diseases have a lot of severe side effects. Liquiritigenin is a flavonoid extracted from Glycyrrhiza glabra roots which has been reported to have positive effects in vitro on osteoblasts activity and bone mineralization as well as inhibitory effe...
Saved in:
Main Authors: | Marta Carnovali (Author), Giuseppe Banfi (Author), Massimo Mariotti (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Hydrogen Prevents Osteoclast Activation in a Glucocorticoid-Induced Osteoporosis Zebrafish Scale Model
by: Marta Carnovali, et al.
Published: (2023) -
Herbal Preparation (Bromelain, Papain, Curcuma, Black Pepper) Enhances Mineralization and Reduces Glucocorticoid-Induced Osteoporosis in Zebrafish
by: Marta Carnovali, et al.
Published: (2021) -
Stereospecific pharmacokinetic characterization of liquiritigenin in the rat
by: Samaa Alrushaid, et al.
Published: (2017) -
The Calcium-Activated Chloride Channel TMEM16A is Inhibitied by Liquiritigenin
by: Mami Kato, et al.
Published: (2021) -
Glucocorticoid-induced osteoporosis: 2013 update
by: M. Mazzantini, et al.
Published: (2014)